Beech
Check out Dendreon's market cap. Then compare it to Prima's. One's a relative goliath, the other a wee minnow.
I'm not saying I would like this to happen. But I'm not running away from the thought, either.
Consolidation in the biotech sector is happening as we speak. And there are good, palpable reasons for that.
Whether it happens now or later is a moot point. A few hundred million dollars is like confetti to some of these megacorporations.
The main game is the end game.
Just imagine if Dendreon or whoever took a 19.9% stake in Prima? The intent would be clear. The outcome a foregone conclusion.
Say $100,000 per treatment multiplied by X number of patients.
You insert the number.
the next must-buy biotech is anyone's guess, page-13
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |